Becton Dickinson Long-Term Investments 2010-2024 | BDX
Becton Dickinson long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Becton Dickinson long-term investments for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
- Becton Dickinson long-term investments for 2023 were $0B, a NAN% decline from 2022.
- Becton Dickinson long-term investments for 2022 were $0B, a NAN% decline from 2021.
- Becton Dickinson long-term investments for 2021 were $0B, a NAN% decline from 2020.
Becton Dickinson Annual Long-Term Investments (Millions of US $) |
2023 |
$ |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$796 |
2015 |
$1,118 |
2014 |
$9 |
2013 |
$ |
2012 |
$ |
2011 |
$ |
2010 |
$ |
2009 |
$ |
Becton Dickinson Quarterly Long-Term Investments (Millions of US $) |
2024-06-30 |
|
2024-03-31 |
|
2023-12-31 |
|
2023-09-30 |
|
2023-06-30 |
|
2023-03-31 |
|
2022-12-31 |
|
2022-09-30 |
|
2022-06-30 |
|
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2018-03-31 |
|
2017-12-31 |
|
2017-09-30 |
|
2017-06-30 |
$43 |
2017-03-31 |
$817 |
2016-12-31 |
$816 |
2016-09-30 |
$796 |
2016-06-30 |
$785 |
2016-03-31 |
$826 |
2015-12-31 |
$1,132 |
2015-09-30 |
$1,118 |
2015-06-30 |
$1,082 |
2015-03-31 |
$1,044 |
2014-12-31 |
|
2014-09-30 |
$9 |
2014-06-30 |
|
2014-03-31 |
|
2013-12-31 |
|
2013-09-30 |
|
2013-06-30 |
|
2013-03-31 |
|
2012-12-31 |
|
2012-09-30 |
|
2012-06-30 |
|
2012-03-31 |
|
2011-12-31 |
|
2011-09-30 |
|
2011-06-30 |
|
2011-03-31 |
|
2010-12-31 |
|
2010-09-30 |
|
2010-06-30 |
|
2010-03-31 |
|
2009-12-31 |
|
2009-09-30 |
|
2009-06-30 |
|
2009-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$67.812B |
$20.178B |
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|